• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Mechanism of the Development of Skin Sclerosis in Scleroderma

Research Project

Project/Area Number 12470176
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Dermatology
Research InstitutionTokyo Medical and Dental University

Principal Investigator

NISHIOKA Kiyoshi  Tokyo Medical and Dental University, Department of Dermatology, Professor, 大学院・医歯学総合研究科, 教授 (20077647)

Co-Investigator(Kenkyū-buntansha) YAMAMOTO Toshiyuki  Tokyo Medical and Dental Univesity, Department of Dermatology, Lecturer, 医学部附属病院, 講師 (30242192)
Project Period (FY) 2000 – 2002
Project Status Completed (Fiscal Year 2002)
Budget Amount *help
¥4,200,000 (Direct Cost: ¥4,200,000)
Fiscal Year 2002: ¥2,100,000 (Direct Cost: ¥2,100,000)
Fiscal Year 2001: ¥2,100,000 (Direct Cost: ¥2,100,000)
KeywordsScleroderma / Bleomycin / TGF-β / Animal model / 強皮症 / ブレオマイシン / 動物モデル / サイトカイン / 線維芽細胞
Research Abstract

We previously established a mouse model for scleroderma by repeated local injections of bleomycin (J Invest Dermatol 1999 ; 112 : 456-462, J Rheumatol 1999 ; 26 : 2628-2634, Arch Dermatol Res 2000 ; 292 : 535-541). In this model, systemic treatment of interferon-γ reduced the development of dermal sclerosis (Arch Dermatol Res 2000 ; 292 : 362-365), whereas halofuginone was not effective (Rheumatology 2002 ; 41 : 594-596). Dermal sclerosis was also induced by bleomycin treatment in SCID mice, suggesting bleomycin-induced scleroderma is T cell independent (J Invest Dermatol 2001 ; 117 : 999-1001). Furthermore, expression of collagen was upregulated in mast cell-deficient mice (Arch Dermatol Res 2001 ; 293 : 532-536). Sclerotic fibroblasts following bleomycin treatment changed the phenotype into myofibroblasts, which were positive for α-smooth muscle actin (α-SMA), and neutralizing anti-TGF-β antibody decreased the number of α-SMA positive fibroblasts. Comparative study among various strains of mice revealed that increased expression and production of TGF-β in the lesional skin of bleomycin-'susceptible' strains.

Report

(4 results)
  • 2002 Annual Research Report   Final Research Report Summary
  • 2001 Annual Research Report
  • 2000 Annual Research Report
  • Research Products

    (26 results)

All Other

All Publications (26 results)

  • [Publications] Yamamoto, T., Takagawa, S., Kuroda, M., Nishioka, K.: "Effect of interferon-γ on experimental scleroderma induced by bleomycin"Arch Dermatol Res.

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Yamamoto, T., Nishioka, K.: "Animal model of sclerotic skin : IV. Induction of dermal sclerosis by bleomycin is T cell independent"J Invest Dermatol.

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Yamamoto, T., Takagawa, S., Nishioka, K.: "Mast cell-independent increase of type I collagen expression in experimental scleroderma induced by bleomycin"Arch Dermatol Res.

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Yamamoto, T., Nishioka, K.: "Animal model of sclerotic skin. V : Increased expression of α-smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma"Clin Immunol.

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Yamamoto, T., Nishioka, K.: "Analysis of the effect of halofuginone in bleomycin-induced scleroderma"Rheumatology.

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Yamamoto T, Takagawa S, Kuroda M, Nishioka K.: "Effect of interferon-γon experimental scleroderma induced by bleomycin"Arch Dermatol Res. 292. 362-365 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Yamamoto T, Kuroda M, Nishioka K.: "Animal model of sclerotic skin. III : Histopathological comparison of bleomycin-induced scleroderma in various mice strains"Arch Dermatol Res. 292. 535-541 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Yamamoto T.&Nishioka K.: "Animal model of sclerotic skin : IV. Induction of dermal sclerosis by bleomycin is T cell independent"J Invest Dermatol. 117. 999-1001 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Yamamoto T, Takagawa S, Nishioka K.: "Mast cell-independent increase of type I collagen expression in experimental scleroderma induced by bleomycin"Arch Dermatol Res. 293. 532-536 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Yamamoto T.&Nishioka K.: "Animal model of sclerotic skin. V : Increased expression of α-smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma"Clin Immunol. 102. 77-83 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Yamamoto T.&Nishioka K.: "Analysis of the effect of halofuginone in bleomycin-induced scleroderma"Rheumatology. 41. 594-596 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Takagawa S, Lakos G, Mori Y, Yamamoto T, Nishioka K, Varga J.: "Sustained activation of fibroblast TGF- β/Smad signaling in murine scleroderma"J Invest Dermatol(accept).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Yamamoto T., Nishioka K.: "Animal model of sclerotic skin : IV. Induction of dermal sclerosis by bleomycin is T cell independent"J Invest Dermatol. 117. 999-1001 (2001)

    • Related Report
      2002 Annual Research Report
  • [Publications] Yamamoto T., Nishioka K.: "Animal model of sclerotic skin. V : Increased expression of α-smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma"Clin Immunol. 102. 77-83 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Yamamoto T, et al.: "Effect of interleukin-10 on the gene expression of type I collagen, fibronectin and decorin in human skin fibroblasts : Differential regulation by transforming growth factor-β and monocyte chemoattractant protein-1/"Biochem Biophys res Commun.. 281. 200-205 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Yamamoto T, et al.: "High expression and autoinduction of monocyte chemoattractant protein-1 in scleroderma fibroblasts"Eur J Immunol.. 31. 2936-2941 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Yamamoto T, et al.: "Expression of monocyte chemoattractant protein-1 in the lesional skin of systemic scleroisis"J Dermatol Sci.. 26. 133-139 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Yamamoto T, et al.: "Role of stem cell factor and monocyte chemoattractant protein-1 in the interaction between fibroblasts and mast cells in fibrosis"J Dermatol Sci.. 26. 106-111 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Yamamoto T, et al.: "Animal model of sclerotic skin. IV : Bleomycin-induced scleroderma in severe combined immunodeficient (SCID) mice"J Invest Dermatol. 117. 999-1001 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Yamamoto T, et al.: "Mast cell-independent increase of type I collagen expression in experimental scleroderma induced by bleomycin"Arch Dermatol Res. 293. 532-536 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Yamamaoto T, et al.: "Animal model of sclerotic skin. I : Local injections of bleomycin induce sclerotic skin mimicking scleroderma."J Invest Dermatol. 112. 456-462 (1999)

    • Related Report
      2000 Annual Research Report
  • [Publications] Yamamoto T, et al.: "Animal model of sclerotic skin. II : Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W^v mice."J Rheumatol. 26. 2628-2634 (1999)

    • Related Report
      2000 Annual Research Report
  • [Publications] Yamamoto T, et al.: "Effect of superoxide dismutase on bleomycin-induced dermal sclerosis : Implications for the treatment of systemic sclerosis."J Invest Dermatol. 113. 843-847 (1999)

    • Related Report
      2000 Annual Research Report
  • [Publications] Yamamoto T, et al.: "Effect of interferon-γ on experimental scleroderma induced by bleomycin."Arch Dermatol Res. 292. 362-365 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Yamamoto T, et al.: "Animal model of sclerotic skin. III : Histopathological comparison of bleomycin-induced scleroderma in various mice strains."Arch Dermatol Res. 292. 535-541 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Yamamoto T, et al.: "Bleomycin increases steady-state levels of type I collagen, fibronectin and decorin mRNAs in human skin fibroblasts."Arch Dermatol Res. 292. 556-561 (2000)

    • Related Report
      2000 Annual Research Report

URL: 

Published: 2001-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi